anazao health semaglutide ObesityWeek® is home to the latest developments in evidence-based obesity science. Come visit part of the team at Booth 811.#obesityweek2025#anazaohealth @zao.by.anazaohealth FDA warns against ‘copies’ of

People with type 2 diabetes already face an elevated baseline risk of pancreatic malignancy due to shared metabolic and inflammatory factors

Shen W, Taylor B, Jin Q, Nguyen-Tran V, Meeusen S, Zhang YQ, et al

These errors have led to adverse effects such as gastrointestinal issues, fainting, dehydration, headaches, gallstones, and acute pancreatitis, with some patients requiring hospitalization

People with type 2 diabetes have a two to three times higher baseline risk of pancreatitis compared to the general population due to shared metabolic risk factors

Hurtado et al., 2024 ( Menopause ) An observational study of postmenopausal women treated with semaglutide found greater weight loss among those using menopausal hormone therapy compared with non-users

Supplementing with L-Carnitine for Fertility Health An interesting and very relevant study has shown that when L-carnitine is supplemented in men, it improves fertility